RAYMOND JAMES & ASSOCIATES - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 43 filers reported holding LEAP THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10,091
-33.4%
29,678
-11.9%
0.00%
Q4 2022$15,155
-67.1%
33,678
-34.9%
0.00%
Q3 2022$46,000
-22.0%
51,737
+1.0%
0.00%
Q2 2022$59,000
-22.4%
51,237
+17.7%
0.00%
Q1 2022$76,000
-33.3%
43,545
+23.8%
0.00%
Q4 2021$114,000
+72.7%
35,172
+6.3%
0.00%
Q3 2020$66,000
-1.5%
33,100
+3.6%
0.00%
Q2 2020$67,00031,9500.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders